Abstract
Daunomycin (NSC-82151) is an antibiotic isolated from cultures of Streptomyces peucetius (DiMarco et al. 1963; DiMarco et al., 1964b). While weakly active against some microorganisms, the drug inhibits the multiplication of bacterial and animal viruses and exhibits a high cytotoxic activity against normal and neoplastic cells (Di Marco et al., 1964a).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Angiuli, R., E. Foresti, L. Riva Di Sanseverino, N. W. Isaacs, O. Kennard, W. D. S. Motherwell, D.L. Wampler, and F. Arcamone: Structure of daunomycin; X-ray analysis of daunomycin solvate. Nature New Biol. 234, 78 (1971).
Apple, M.H., and C.M. Haskell: Potent inhibition of sarcoma virus RNA-directed RNA:DNA duplex synthesis and arrest of ascites murine leukemia and sarcoma in vivo by anthracyclines. Physiol. Chem. Physics 3, 307 (1971).
Arcamone, F., W. Barbieri, G. Franceschi e S. Penco: Trasformazione della daunomicina in adriamicina. Chim. Ind. (Milan) 51, 834 (1969a).
Arcamone, F., G. Cassinelli, G. Fantini, A. Grein, P. Orezzi, C. Pol, and C. Spalla: Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius. Biotechnol. Bioeng. 11, 1101 (1969 b).
Arcamone, F., G. Cassinelli, G. Franceschi, R. Mondelli, P. Orezzi e S. Penco: Struttura e stereochimica della daunomicina. Gazz. Chim. Ital. 100, 949 (1970).
Arcamone, F., G. Cassinelli, G. Franceschi, P. Orezzi, and R. Mondelli: The absolute stereochemistry of daunomycin. Tetrahedron Letters 1968a, 3353.
Arcamone, F., G. Cassinelli, P. Orezzi, G. Franceschi, and R. Mondelli: Daunomycin. II. The structure and steoreo-chemistry of daunosamine. J. Am. Chem. Soc. 86, 5335 (1964a).
Arcamone, F., G. Franceschi, P. Orezzi, C. Cassinelli, W. Barbieri, and R. Mondelli: Daunomycin. I. The structure of daunomycinone. J. Am. Chem. Soc. 86, 5334 (1964b).
Arcamone, F., G. Franceschi, P. Orezzi, S. Penco, and R. Mondelli: The structure of daunomycin. Tetrahedron Letters 1968b, 3349.
Arcamone, F., G. Franceschi et S. Penco: Substances antibiotiques et procédé pour leur préparation. Belg. Patent 732, 968 (1969c).
Arcamone, F., G. Franceschi et S. Penco: Procédé de préparation de l’adriamycine et de l’adriamycinone. Belg. Patent 731, 398 (1969d).
Arcamone, F., G. Franceschi, S. Penco, and A. Selva: Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic. Tetrahedron Letters 13, 1003 (1969 e).
Bachur, N.R.: Daunorubicinol, a major metabolite of daunorubicin: isolation from human urine and enzymatic reactions. J. Pharmacol. Expl. Therap. 177, 573 (1971).
Bachur, N.R., and M. Gee: Daunorubicinol metabolism by rat tissue preparations. J. Pharmacol. Exptl. Therap. 177, 657 (1971).
Bachur, N.R., A.L. Moore, J.B. Bernstein, and A. Liu: Tissue distribution and disposition of daunomycin (NSC-82151) in mice: Fluorometric and isotopic methods. Cancer Chemotherapy Rept. 54, 89 (1970).
Baer, H.H., K. Capek, and M.C. Cook: Synthesis of 3-acetamide 2,3,6-trideoxy-D-lyxo-hexose (N-acetyl-D-daunosamine) and its D-arabino isomer. Can. J. Chem. 47, 89 (1969).
Berg, H., u. K. Eckardt: Zur Interaktion von anthracyclin und anthracyclinonen mit DNS. Z. Naturforsch. 25b, 4 (1970).
Bernard, J., R. Paul, M. Boiron, C. Jacquillat, u. R. Maral: Rubidomycin. Berlin-Heidelberg-New York: Springer 1969.
Bertazzoli, C., T. Chieli, G. Ferni, G. Ricevuti, and E. Solcia: Chronic toxicity of adriamycin. A new antineoplastic antibiotic. Toxicol. Appl. Pharmacol. 21, 287 (1972).
Bertazzoli, C., T. Chieli, M. Grandi, and G. Ricevuti: Adriamycin toxicity data. Experientia 26, 389 (1970).
Bhuyan, B.K., and C.G. Smith: Differential interaction of nogalamycin with DNA of varying base composition. Proc. Natl. Acad. Sci. U.S. 54, 566 (1965).
Biedler, J.L., and H. Riehm: Cellular resistance to actinomycin d in Chinese hamster cells in vitro: Cross-resistance, radio-autographic, and cytogenetic studies. Cancer Res. 30, 1174 (1970).
Blake, A., and A.R. Peacocke: The interaction of amino acridines with nucleic acids. Biopolymers 6, 1225 (1968).
Bonadonna, G., and S. Monfardini: Cardiac toxicity of daunomycin. Lancet 1969-I, 837.
Bonadonna, G., S. Monfardini, M. De Lena, F. Fossati-Bellani, and G. Beretta: Phase I and preliminary phase II evaluation of adriamycin (NSC-123, 127). Cancer Res. 30, 2572 (1970).
Brachnikova, M.G., N.V. Kostantinova, F.A. Pomaskova, and B.M. Zacharov: Physico-chemical properties of antitumor antibiotic rubidomycin, produced by Act. coeruleorubidus. Antibiotiki 11, 763 (1966).
Brahic, M., and Tamalet, J.: Effects of actinomycin D and rubidomycin on sindbis virus replication. Compt. Rend. Soc. Biol. 162, 1557 (1969).
Burka, B., E.H. Herman, and H. Vick: Role of the sympathetic nervous system in daunomycin-induced arrhythmia in the monkey. Brit. J. Pharmacol. 39, 501 (1970).
Calendi, E., R. Dettori, and M.G. Neri: Filamentous sex-specific bacteriophages of E. Coli K 12. IV-Studies on physico-chemical characteristics of bacteriophage Ec9. Giorn. Microbiol. 14, 227 (1966).
Calendi, E., A. Di Marco, M. Reggiani, B.M. Scarpinato, and L. Valentini: On physico-chemical interactions between daunomycin and nucleic acids. Biochim. Biophys. Acta 103, 25 (1965).
Casazza, A.M., A. Di Marco, and G. Di Cuonzo: Interference of daunomycin and adriamycin on the growth and regression of murine sarcoma virus (Moloney)-induced tumors in mice. Cancer Res. 31, 1971 (1971).
Casazza, A.M., C. Gambarucci, and R. Silvestrini: Effects of daunomycin and adriamycin on the murine sarcoma virus (Moloney) in vitro. Europ. J. Clin. Biol. Res. 17, 622 (1972).
Chandra, P., F. Zunino, A. Götz, D. Gericke, R. Thorbeck, and A. Di Marco: Specific inhibition of DNA-polymerase from RNA tumor viruses by some new daunomycin derivatives. FEBS Letters 21, 264(1972).
Cohen, A., L.E. Crook, and K.R. Rees: Effect of daunomycin Vaccinia nucleic acid synthesis. Int. Virol. 2, 2nd Int. Congr. Virol., Budapest 1971, pp. 282. Basel: Karger 1971.
Cohen, A., E.M. Harley, and K.R. Rees: Antiviral effect of daunomycin. Nature 222, 36 (1969).
Crook, L.E., K.R. Rees, and A. Cohen: Effect of daunomycin on HeLa cell nucleic acid synthesis. Biochem. Pharmacol. 21, 281 (1972).
Dano, K.: Development of resistance to daunomycin (NSC-82151) in Ehrlich ascites tumor. Cancer Chemotherapy Rept. 55, 133 (1971).
Di Fronzo, G., and R.A. Gambetta: “In vivo” studies on the distrubtion of 3H-daunomycin in tumors and in different tissues of the mouse. Europ. J. Clin. Biol. Res. 16, 50 (1971a).
Di Fronzo, G., R.A. Gambetta, and L. Lenaz: Distribution and metabolism of adriamycin in mice. Comparison with daunomycin. Europ. J. Clin. Biol. Res. 16, 572 (1971b).
Di Marco, A.: Daunomycin and related antibiotics. Antibiotics, vol. I., p. 190 (eds. Gottlieb and Shaw). Berlin-Heidelberg-New York: Springer 1967a.
Di Marco, A.: La daunoblastina, Milano: Minerva Medica 1970.
Di Marco, A.: Adriamycin. The therapeutic activity on experimental tumors. International Symposium on Adriamycin, Milano, 1971a.
Di Marco, A., G. Boretti e A. Rusconi: Trasformazione metabolica della daunomicina da parte di estratti di tessuti. II Farmaco 7, 535 (1967b).
Di Marco, A., M. Gaetani, L. Dorigotti, M. Soldati, and O. Bellini: Daunomycin: A new antibiotic with antitumor activity. Cancer Chemotherapy Rept. 38, 31 (1964a).
Di Marco, A., M. Gaetani, P. Orezzi, B. Scarpinato, R. Silvestrini, M. Soldati, T. Dasdia, and L. Valentini: Daunomycin, a new antibiotic of the rhodomycin group. Nature 201, 706 (1964 b).
Di Marco, A., M. Gaetani, P. Orezzi, and M. Soldati: Antitumor activity of a new antibiotic: Daunomycin, IIIrd Int. Congr. of Chemistry, Stuttgart, 1963.
Di Marco, A., M. Gaetani, and B. Scarpinato: Adriamycin (NSC-123, 127): A new antibiotic with antitumor activity. Cancer Chemotherapy Rept. 53, 33 (1969).
Di Marco, A., L. Lenaz, A.M. Casazza, and B. Scarpinato: Activity of adriamycin (NSC-123, 127) and daunomycin (NSC-82151) on mouse mammary carcinoma. Cancer Chemotherapy Rept. 54, 153 (1972 a).
Di Marco, A., and A. Rusconi: Action mechanism and metabolic transformation of daunomycin. Gann Monographies 2, 23 (1967c).
Di Marco, A., R. Silvestrini, T. Dasdia, and S. Di Marco: Nucleolar and chromosomal origin of nuclear RNA and its passage to cytoplasm. Riv. Ital. Istochimica 11, 211 (1965 a).
Di Marco, A., R. Silvestrini, S. Di Marco, and T. Dasdia: Inhibition effect of the new cytotoxic antibiotic daunomycin on nucleic acids and mitotic activity of HeLa cells. J. Cell Biol. 27, 545 (1965b).
Di Marco, A., M. Soldati, A. Fioretti, and T. Dasdia: Activity of daunomycin, a new antitumor antibiotic, on normal and neoplastic cells grown in vitro. Cancer Chemotherapy Rept. 38, 39 (1964c).
Di Marco, A., M. Terni, R. Silvestrini, B. Scarpinato, E. Biagioli, and A. Antonelli: Effect of daunomycin on Herpes Virus hominis in human cell. Giorn. Microbiol. 16, 25 (1968).
Di Marco, A., F. Zunino, P. Orezzi, and R.A. Gambetta: Interaction of daunomycin with nucleic acids. Effect of photo-irradiation of the complex. Experientia 28, 327 (1972 b).
Di Marco, A., F. Zunino, R. Silvestrini, C. Gambarucci, and R.A. Gambetta: Interaction of some daunomycin derivatives with DNA and their biological activity. Biochem. Pharmacol. 20, 1323 (1971b).
Dorigotti, L.: Studio al microscopio elettrico delle modifícazioni indotte dalla daunomicina sulle cellule HeLa. Tumori 50, 117 (1964).
Dubost, M., P. Ganter, R. Maral, L. Ninet, S. Pinnet, J. Preud’Homme et G.H. Werner: Un nouvel antibiotique a propriétés antitumorales. Compt. Rend. 257, 1813 (1963).
Dudnik, Yu. V., and E.M. Netyksa: Interaction of sibiromycin with DNA. Exclusion of actinomycin D and olivomycin A from complexes with DNA. Antibiotiki 17, 44 (1972).
Dusonchet, L., N. Gebbia, and F. Gerbiasi: Spectrophotofluorometric characterization of adriamycin, a new antitumor drug. Pharmacol. Res. Commun. 3, 55 (1971).
Ellen, K.A.O., and S.L. Rhode: Selective inhibition of ribosomal RNA synthesis in HeLa cells by nogalamycin, a dA.dT binding antibiotic. Biochim. Biophys. Acta 209, 415 (1970).
Gause, G.F.: Aspects of antibiotics research. Chem. & Ind. (London) 36, 1506 (1966).
Hartmann, G., H. Goller, K. Koschel, W. Kersten u. H. Kersten: Hemmung der DNA-abhängigen RNA- und DNA-Synthese durch Antibiotica. Biochem. Z. 341, 126 (1964).
Herman, E.H., P. Schein, and R.M. Farmar: Comparative cardiac toxicity of daunomycin in three rodent species. Proc. Soc. Exptl. Biol. Med. 130, 1098 (1969).
Herman, E.H., P. Schein, and R.M. Farmar: Influence of pharmacologic or physicologic pretreatment on acute daunomycin cardiac toxicity in the hamster. Toxicol. Appl. Pharmacol. 16, 335 (1970).
Honikel, K.: Wirkung von Antibiotica auf die DNA-gesteurte DNA-Polymerase-Reaktion. PhD. Thesis, Univ. Würzburg, 1968.
Hoshino, A., T. Kato, H. Amo, and K. Ota: Antitumor effects of adriamycin on Yoshida rat sarcoma and L 1210 mouse leukemia. Cross resistance and combination chemotherapy. International Symposium on Adriamycin, Milano, 1971.
Isetta, A.M., C. Intini, and L. Soldati: On the immunodepressive action of adriamycin. Experientia 27, 202 (1971).
Kersten, W.: Inhibition of RNA synthesis by quinone antibiotics. In: Progress in molecular and subcellular biology, vol. 2, 48. Berlin-Heidelberg-New York: Springer 1971.
Kersten, W., u. H. Kersten: Die Bindung von Daunomycin, Cinerubin und Chromomycin A3 und Nucleinsäuren. Biochem. Z. 341, 174 (1965).
Kersten, W., and H. Kersten: Interaction of antibiotics with nucleic acids. In: Molecular association in biology, p. 289. New York: Academic Press 1968.
Kersten, W., H. Kersten, and W. Szybalski: Physico-chemical properties of complexes between DNA and antibiotics which affect RNA synthesis. Biochemistry 5, 236 (1966).
Kessel, D., V. Botterill, and L. Wodinsky: Uptakte and retention of daunomycin by mouse leukemic cells as factors in drug response. Cancer Res. 28, 938 (1968).
Kim, K.H., A.S. Gelbard, B. Djordjevic, S.H. Kim, and A.G. Perez: Action of daunomycin on the nucleic acid metabolism and viability of HeLa cells. Cancer Res. 28, 2437 (1968).
Kim, S.H., and J.H. Kim: Lethal effect of adriamycin on the division of HeLa cells. Cancer Res. 32, 323 (1972).
Lunel, J., u. J. Preud’Homme: Deutsches Patentamt Offenlegungsschrift 1911249, Okt. 2, (1969).
Marsh, J.P., Jr., L.W. Mosher, E.M. Action, and L. Goodman: The synthesis of daunosamine. Chem. Commun. 973 (1967).
Müller, W., and D.M. Crothers: Studies of the binding of actinomycin and related compounds to DNA. J. Mol. Biol. 35, 251 (1968).
Natale, N., e P. Mocarelli: Depressione immunitaria da daunomicina. Tumori 55, 409 (1969).
Paoletti, J., and J.B. Le Pecq: The change of the torsion of the DNA helix caused by intercalation. I. A discussion of the two different possibilities, winding and unwinding. Biochimie 53, 969 (1971).
Parisi, B., and A. Soller: Studies on the antiphage activity of daunomycin. Giorn. Microbiol. 12, 183 (1964).
Penco, S.: New glycosides of daunomycinone. Chim. Ind. (Milan) 50, 908 (1968).
Penman, S., C. Vesco, and M. Penman: Localization and kinetics of formation of nuclear heterodisperse RNA, cytoplasmic heterodisperse RNA and polyribosome-associated messenger RNA in HeLa cells. J. Mol. Biol. 34, 49 (1968).
Perry, R.R.: Selective effects of actinomycin D in the intracellular distribution of RNA synthesis in tissue culture cells. Exptl. Cell Res. 29, 400 (1963).
Picone, M.A., and A. Traine: Pharmacokinetic characteristics of daunomycin, an antibiotic with antitumor action. Arzneimittel-Forsch. 20, 88 (1970).
Pigram, W.J., W. Fuller, and L.D. Hamilton: Stereochemistry of intercalation: Interaction of daunomycin with DNA. Nature New Biol. 235, 17 (1972).
Pittillo, R.F., and D.E. Hunt: Biologic activity of daunomycin (NSC-82151) in microbial systems. Cancer Chemotherapy Rept. 52, 707 (1968).
Richardson, A.C.: The synthesis of N-benzoyl-D-daunosamine. Carbohydrate Res. 4, 422 (1967).
Rusconi, A.: Different binding sites in DNA for actinomycin and daunomycin. Biochim. Biophys, Acta 123, 627 (1966).
Rusconi, A., e E. Calendi: Azione della daunomicina sulla sintesi nucleica in cellule di epatoma. Tumori 50, 261 (1964).
Rusconi, A., and E. Calendi: Action of daunomycin on nucleic acid metabolism. Biochim. Biophys. Acta 119, 413 (1966).
Rusconi, A., G. Di Fronzo, and A. Di Marco: Distribution of tritiated daunomycin (NSC-82151) in normal rats. Cancer Chemotherapy Rept. 52, 331 (1968).
Rusconi, A., and A. Di Marco: Inhibition of nucleic acid synthesis by daunomycin and its relationship to the uptake of the drug in HeLa cells. Cancer Res. 29, 1509 (1969).
Sandberg, J.S., F.L. Howsden, A. Di Marco, and A. Goldin: Comparison of the antileukemic effect in mice of adriamycin (NSC-123, 127) with daunomycin (NSC-82151). Cancer Chemotherapy Rept. 54, 1 (1970).
Sanfilippo, A., e E. Mazzoleni: Attività antifagica dell’antibiotico daunomicina. Giorn. Microbiol. 12, 83 (1964).
Saucier, J.M., B. Festy, and J.B. Le Pecq: The change of the torsion of the DNA helix caused by intercalation. II. Measurement of the relative change of torsion induced by various intercalating drugs. Biochimie 53, 973 (1971).
Silvestrini, R., A. Di Marco, and T. Dasdia: Interference of daunomycin with metabolic events of the cell cycle in synchronized cultures of rat fibroblasts. Cancer Res. 30, 966 (1970).
Silvestrini, R., A. Di Marco, S. Di Marco, and T. Dasdia: The action of daunomycin on the metabolism of nucleic acids of normal and neoplastic cells growing in vitro. Tumori 49, 399 (1963a).
Silvestrini, R., and M. Gaetani: The action of daunomycin on the metabolism of nucleic acids of Ehrlich ascites tumor cells. Tumori 49, 389 (1963 b).
Simard, R.: The binding of actinomycin D-3 H to heterochromatin as studied by quantitative high resolution radioautography. J. Cell Biol. 35, 716 (1967).
Smith, B.: Damage to intrinsic cardiac nervous by rubidomycin (daunorubicine). Brit. Heart J. 31, 607 (1969).
Spikes, J.D.: Photophysiology, vol. III, p. 33–64. New York: Academic Press 1968.
Sternberg, S.S.: Cross-striated fibrils and other ultrastructural alterations in glomeruli of rats with daunomycin nephrosis. Lab. Invest. 23, 39 (1970).
Sternberg, S.S., and S.F. Philips: Biphasic intoxication and nephrotic syndrome in rats given daunomycin. Proc. Am. Ass. Cancer Res. 8, 64 (1967).
Theologides, A., J.M. Yarbro, and B.J. Kennedy: Daunomycin inhibition of DNA and RNA synthesis. Cancer 21, 16 (1968).
Venditti, J.M., J. Abbot, A. Di Marco, and A. Goldin: Effectiveness of daunomycin (NSC-82151) against experimental tumors. Cancer Chemotherapy Rept. 50, 659 (1966).
Verini, M.A., A.M. Casazza, A. Fioretti, F. Rodenghi, and M. Ghione: Photodynamic action of daunomycin. II. Effect on animal viruses. Giorn. Microbiol. 16, 55 (1968).
Ward, D., E. Reich, and I.H. Goldberg: Base specificity in the interaction of polynucleotides with antibiotics drugs. Science 149, 1259 (1965).
Waring, M.J.: Drugs which affect the structure and function of DNA. Nature 219, 1320 (1968).
Waring, M.J.: Variation of the supercoilds in closed circular DNA by binding of antibiotics and drugs: Evidence for molecular models involving intercalation. J. Mol. Biol. 54, 247 (1970).
Whang-Peng, J., B.G. Leventhal, J.W. Adamson, and S. Perry: The effect of daunomycin on human cells in vivo and in vitro. Cancer 23, 113 (1969).
White, H.L., and J.R. White: Hedamycin and rubiflavin complexes with deoxyribonucleic acid and other polynucleotides. Biochemistry 8, 1030 (1969).
Yesair, D.W., M.A. Asbell, R. Bruni, F.J. Bullock, and E. Schwartzbach: Pharmacokinetics and metabolism of adriamycin and daunomycin. Internation Symposium on Adriamycin, Milano, 1971.
Zeleznick, L.D., and C.M. Weeney: Inhibition of deoxyribonuclease action by nogalamycin and U-12241 by their interaction with DNA. Arch. Biochem. Biophys. 120, 292 (1967).
Zunino, F.: Studies on the mode of interaction of daunomycin with DNA. FEBS Letters 18, 249 (1971).
Zunino, F., R.A. Gambetta, A. Di Marco, and A. Zaccara: Interaction of daunomycin and its derivatives with DNA. Biochim. Biophys. Acta, 277, 489 (1972).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Di Marco, A., Arcamone, F., Zunino, F. (1975). Daunomycin (Daunorubicin) and Adriamycin and Structural Analogues: Biological Activity and Mechanism of Action. In: Corcoran, J.W., Hahn, F.E., Snell, J.F., Arora, K.L. (eds) Mechanism of Action of Antimicrobial and Antitumor Agents. Antibiotics, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46304-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-46304-4_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46306-8
Online ISBN: 978-3-642-46304-4
eBook Packages: Springer Book Archive